Atrium Therapeutics Inc

Atrium Therapeutics Inc(RNA)价格预测

$8.320

-0.345 (-4.15%)收盘时

价格预测

1-Day Price Prediction
+0.58%
1-Week Prediction
-0.36%
1-Month Prediction
—
2026 Prediction
—
2030 Prediction
—

在 App 中打开以解锁更长周期的预测。

Loading chart…

RNA 相似图表分析预测

Alphio's RNA stock price prediction model matches the current Atrium Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.37 (+0.58%). The 1-week path is $8.29 (-0.36%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

该买入 Atrium Therapeutics Inc 股票吗?

Avidity Biosciences Inc (RNA) is a good buy right now due to its current price of $8.55, which is significantly below its 52-week high of $73.06, indicating substantial upside potential. The RSI of 70.53 suggests that the stock is currently overbought, but the recent 5-day change of +6.21% and a strong upcoming clinical trial could drive further interest. However, the main risk is the significant insider selling, which has increased by 200.63% over the last month, indicating potential concerns about future performance.

RNA 股价于 Thursday 收于 $8.32,此前下跌 -4.15%

Atrium Therapeutics Inc (RNA) last closed at $8.3199997, losing -4.15%. These facts feed the 1-day and 1-week RNA price prediction above.

预测驱动因素

Atrium Therapeutics Inc(RNA)的预测驱动因素综合了相似的图表形态、季节性与移动平均线。

Similar patterns

Negative

Bearish

Seasonality

Positive

Bullish

SMA 20

Positive

Bullish

SMA 200

Negative

Bearish

相似图表形态

近期走势与 RNA 最接近的股票,按相似度排序。

RNA 季节性分析

Historically the probability of a positive November return for RNA is 90.70%. December offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易